Anthony S. Murabito
Corporate Officer/Principal bij New Jersey Society of Health-System Pharmacists
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
James Ford | M | - | 29 jaar | |
David Redfern | M | 57 | 30 jaar | |
Timothy Woodthorpe | M | - | 24 jaar | |
Graham Rivers | M | - | 26 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Julian Heslop | M | 70 | 13 jaar | |
Kurt C. Gunter | M | 69 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 5 jaar |
Robert Carr | M | - | 26 jaar | |
William Louv | M | - | 21 jaar | |
Michèle Barzach | M | - | 7 jaar | |
John David Coombe | M | 79 | 5 jaar | |
Peter Traber | M | 69 | 3 jaar | |
Richard Sykes | M | 79 | 7 jaar | |
Alex Howarth | M | 55 | 10 jaar | |
Christopher Viehbacher | M | 64 | 20 jaar | |
Murray Stewart | M | 63 | 17 jaar | |
Robert P. Roche | M | 68 | - | |
John Lepore | M | - | 15 jaar | |
Jay C. Strum | M | - | 14 jaar | |
Thierry Loriot | M | - | - | |
Roger Connor | M | - | 24 jaar | |
Charlie Sanders | M | 91 | 5 jaar | |
Catherine Sohn | M | 71 | 28 jaar | |
James Wu | M | - | 10 jaar | |
Robin M. Young | M | 57 | 7 jaar | |
David Wheadon | M | 66 | 5 jaar | |
Lawson Macartney | M | 66 | 12 jaar | |
Anne Brindley | M | 59 | 3 jaar | |
David M. Pernock | M | 69 | 16 jaar | |
Peter John Murray | M | - | - | |
Carol Ashe | F | 66 | 13 jaar | |
Duncan Learmouth | M | - | - | |
Neil Pegg | M | - | - | |
Steven Gelone | M | 56 | 2 jaar | |
Gregg Brandyberry | M | - | 16 jaar | |
Dean Hakanson | M | 72 | 7 jaar | |
Michael Allen Luther | M | 67 | 15 jaar | |
Myra Rosario Herrle | M | - | 9 jaar | |
Tina Russell | F | - | 1 jaar | |
Song Gao | M | 52 | 22 jaar | |
Monica Viziano | M | 57 | 6 jaar | |
Hu Li | M | 59 | 19 jaar | |
Ian Pitfield | M | 58 | 23 jaar | |
Lisa Trivison Beck | F | 62 | 24 jaar | |
Melissa Beelen | F | - | 12 jaar | |
David Rowe | M | 57 | 20 jaar | |
Edgar Cale | M | 60 | 21 jaar | |
Lisa Bright | F | 56 | 17 jaar | |
Kimberly Park | F | 60 | 12 jaar | |
Daniel G. Marquess | M | 55 | 4 jaar | |
Steve Damment | M | - | 17 jaar | |
Deborah Waterhouse | F | 57 | - | |
Vivid Sehgal | M | 56 | 6 jaar | |
Brian Blakey | M | 61 | 6 jaar | |
Nick Hirons | M | - | - | |
Adi Mohanty | M | 57 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 jaar |
Scott Fields | M | 69 | 5 jaar | |
Robert G. Pietrusko | M | 76 | 1 jaar | |
David Laskow-Pooley | M | 69 | 8 jaar | |
Randall K. Johnson | M | 77 | 20 jaar | |
Tamar Howson | F | 75 | 9 jaar | |
Richard A. Franco | M | 82 | 12 jaar | |
Howard H. Pien | M | 66 | 12 jaar | |
Paul W. Hawran | M | 71 | 9 jaar | |
George Poste | M | 79 | 7 jaar | |
Konstantinos Andrikopoulos | M | 58 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 jaar |
Joseph M. Spagnardi | M | 60 | 11 jaar | |
Faheem Hasnain | M | 65 | 14 jaar | |
Leslie Hudson | M | 76 | 6 jaar | |
Paul Magrez | M | - | 4 jaar | |
Ursula B. Bartels | F | 66 | 11 jaar | |
Maxine Gowen | M | 66 | 10 jaar | |
Thomas Sciascia | M | 70 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 jaar |
Robert Ruffolo | M | 74 | 16 jaar | |
Tim Tyson | M | 71 | 6 jaar | |
Dean Mitchell | M | 68 | 15 jaar | |
Roger L. Hawley | M | 71 | 14 jaar | |
Joseph Schachle | M | 59 | 3 jaar | |
Renato Fuchs | M | 80 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 4 jaar |
William J. Fallon | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 jaar |
Lieven Nuyttens | M | 57 | 6 jaar | |
David Lawrence | M | 61 | 13 jaar | |
Franco di Muzio | M | - | 8 jaar | |
Paul Carter | M | 63 | 10 jaar | |
Margaret Dalesandro | M | 77 | 2 jaar | |
Marc Rubin | M | 69 | 13 jaar | |
Christopher J. Morl | M | 65 | 3 jaar | |
Dimitri Dimitriou | M | - | 5 jaar | |
Douglas B. Snyder | M | 60 | 6 jaar | |
Shirish Hirani | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 jaar |
Daniel Phelan | M | 74 | 31 jaar | |
Argeris Karabelas | M | 71 | 6 jaar | |
Adrian Rawcliffe | M | 52 | 17 jaar | |
Lisa Porter | M | 60 | 5 jaar | |
Michael V. Milburn | M | - | 10 jaar | |
Elaine Jones | M | 69 | - | |
Christoph Adams | M | 67 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 7 jaar |
Gary Patou | M | 65 | 5 jaar | |
Leon Palandjian | M | 54 | 3 jaar | |
Geoffrey Nichol | M | 69 | 7 jaar | |
Wissam Al-Adani | M | 50 | 6 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigd Koninkrijk | 92 | 92.00% |
Verenigde Staten | 8 | 8.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Anthony S. Murabito
- Persoonlijk netwerk